Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Financial Results
Halfway through 2018, three of the leading animal health players have made great strides in terms of top-line growth. Others have fallen foul of currency exchange issues. Animal Pharm editor Joseph Harvey looks out how the first six months panned out for the top 10.
Bayer Animal Health's second quarter of 2018 has shown a small recovery after losses at the beginning of the year.
Dechra Pharmaceuticals has sustained its rapid growth of recent years and reported a sales increase of around 13% for fiscal 2018.
US distributor Patterson Companies has reported a 6% increase in first-quarter revenues.
US firm Phibro Animal Health has recorded a 9% increase in sales in the fourth quarter of its fiscal 2018, backed by international growth.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.